Developer docs
API playgroundTry for free, no card

Search company profiles

Calcivis

Full company profile

uuid0002spm

Namestring
Calcivis
Legal namestring
Calcivis, Inc.
Websiteurl
calcivis.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Calcivis is an Edinburgh-based medical device company that develops and commercializes the CALCIVIS Imaging System, a chairside dental diagnostic that uses a recombinant bioluminescent photoprotein to visualize free calcium ions released from actively demineralizing tooth surfaces. The system pairs a biologic reagent (sprayed onto the tooth) with a custom imaging device and proprietary overlay software to produce real-time demineralization maps, enabling dental practitioners to differentiate active from inactive caries lesions and detect subclinical demineralization that conventional visual-tactile methods miss in up to 70% of pre-cavitated cases. The company positions the product as the first application of bioluminescence in preventive dentistry, addressing a global disease — dental caries — that affects roughly 35% of the world population.

The business operates a hybrid capital-equipment + consumable model: the imaging device represents a one-time capital sale to dental practices, while the photoprotein reagent is consumed per procedure and generates recurring usage-based revenue. Calcivis sells exclusively through a direct enterprise field-sales motion with consultative demos, currently limited to the United States following FDA Premarket Approval secured in January 2024 (the first Scottish medical device to achieve this milestone). The company also holds a UKCA mark for the UK market and has publicly stated plans for UK and European expansion once the US launch is established.

The company was co-founded in 2012 by Adam Christie and Bruce Vernon, is backed by the Scottish National Investment Bank, Investment Fund for Scotland, Archangels, and Scottish Enterprise, and transitioned leadership in April 2025 to Greg Sheehan (formerly VP of Global Endodontic Platform at Dentsply Sirona) to professionalize the commercial phase. Operating geographies are the UK (headquarters at Edinburgh BioQuarter) and the US (Milton, Massachusetts), with headcount in the 1-10 range and total disclosed funding of approximately £28M+ across nine rounds since 2012.

Short descriptiontext

Calcivis is an Edinburgh-based medical device company that sells the CALCIVIS Imaging System, a chairside dental diagnostic using bioluminescent photoprotein technology to detect active tooth demineralization in real time. It targets US dental practices with a capital-device plus consumable model following FDA Premarket Approval in January 2024.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersEdinburgh, United Kingdom
HQ citystring
Edinburgh
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dental imaging systems, caries detection devices, bioluminescent diagnostics, preventive dentistry equipment, dental medical devices
Industry2 codes
PRIMARYHLABAIAL
Dental Imaging Equipment Service, Calibration & QA Providers
Healthcare & Life Sciences/Dental Care Services/Dental Radiology & Imaging Centers
SECONDARYHLACALAK
Teleradiology Platforms & Reading Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code1 code
  • Dental Equipment and Supplies Manufacturing339114
SIC code1 code
  • Dental Equipment & Supplies3843
Product category
Dental Diagnostic Imaging Equipment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales (Imaging System)
TypeOne Time License
Description

Sale of the CALCIVIS Imaging System device - a dental imaging apparatus that includes the photoprotein delivery and imaging capture technology. This is a capital equipment sale model typical for medical devices.

scottishlifesciencesassociation.org.uk
2Consumables (Photoprotein Agent)
TypeUsage Based
Description

Recurring revenue from the biologic diagnostic agent (photoprotein) that is consumed during each imaging procedure. The photoprotein is sprayed onto tooth surfaces and reacts with calcium ions to produce the bioluminescent signal.

calcivis.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Marketing or Sales, Personnel, Supply Chain, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Calcivis develops and commercializes the CALCIVIS Imaging System, a dental medical device that uses a proprietary recombinant photoprotein to react with free calcium ions released from actively demineralizing tooth surfaces, producing a real-time bioluminescent signal. The system consists of an imaging device, a consumable photoprotein reagent, and proprietary software that overlays visible and luminescent images to provide chairside maps of active caries lesion demineralization, enabling early detection and monitoring of tooth decay.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Conventional diagnostic methods miss up to 70% of pre-cavitated caries lesions
+3 more records
Product overview1 text field

Calcivis offers a single unified product: the CALCIVIS® Imaging System, which consists of a bioluminescent photoprotein reagent (a biologic diagnostic agent), an imaging device, and proprietary software. The system represents the first application of bioluminescence in preventive dentistry, enabling real-time chairside assessment of caries lesion activity by detecting free calcium ions released during active demineralization. The imaging device applies the photoprotein and simultaneously captures bioluminescent reaction images, which are overlaid with visible images to generate demineralization maps for early detection and monitoring of dental caries.

Product and service1 record
1CALCIVIS Imaging System
CategoryDental diagnostic imaging system (medical device)
Description

A bioluminescence-based dental imaging system that detects and assesses demineralization associated with carious lesions in real time. It consists of a hand-held imaging device, a consumable recombinant photoprotein reagent that reacts with free calcium ions released from actively demineralizing tooth surfaces, and proprietary software that overlays visible and luminescent images to provide chairside demineralization maps. It is intended for general dental practitioners, hygienists, and dental practices performing routine examinations and preventive dentistry for patients aged 6 and above, and is currently available for sale in the United States only.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Manufacturer of DIAGNOdent, the leading laser fluorescence caries detection device used chairside by dental practices. Most direct competitor to CALCIVIS in the early caries detection workflow, serving the same preventive dentistry customer segment.

TypeBroad incumbent
Description

Align Technology (iTero) sells intraoral scanners and NIRI (near-infrared imaging) caries detection capability within its imaging platform. Broad incumbent adding AI-driven caries detection features that could compete with or complement CALCIVIS in digitally-enabled dental practices.

TypeDirect peer
Description

Manufacturer of Sopro intraoral cameras and the SoproLife/SOPROcare fluorescence-based caries detection devices. Directly competes with CALCIVIS in the dental imaging and caries detection category, targeting the same dental practitioner use case.

TypeBroad incumbent
Description

US manufacturer of dental equipment including imaging systems, chairs, and delivery units. Serves the same dental practice customer base with overlapping capital equipment sales motion into general dentistry offices.

5Dentsply Sirona
TypeBroad incumbent
Description

Largest global dental equipment and consumables manufacturer offering imaging systems (X-ray, intraoral cameras), restorative materials, and endodontic solutions. New Calcivis CEO Greg Sheehan previously served as VP of Global Endodontic Platform here, making it the most strategically relevant incumbent peer.

TypeBroad incumbent
Description

Global dental technology company offering TRIOS intraoral scanners, imaging software, and CAD/CAM workflows. Adjacent competitor in dental digital imaging with overlapping practitioner customers and growing AI-powered diagnostic capabilities.

TypeDirect peer
Description

US-based manufacturer of dental imaging systems including Spectra (caries detection camera) and ProVecta intraoral imaging. Direct competitor in the dental imaging device category with overlapping sales channels into North American dental practices.

TypeBroad incumbent
Description

Japanese manufacturer of dental handpieces, scalers, and small equipment sold globally through dental distribution. Comparable in selling capital equipment and consumables into the same dental practice channel as Calcivis targets.

TypeEmerging player
Description

Developer of The Canary System, a laser-based caries detection device using PTR-LUM technology. Niche emerging competitor pursuing the same chairside early caries detection opportunity with a different underlying physics.

10Wagstaff & Cartwright / Vista Dental
TypeEmerging player
Description

Smaller dental technology manufacturer selling diagnostic and preventive products into dental practices. Comparable go-to-market through dental distribution and overlapping preventive dentistry positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Calcivis

Dental Diagnostic Imaging Equipmentcalcivis.com

Calcivis is an Edinburgh-based medical device company that sells the CALCIVIS Imaging System, a chairside dental diagnostic using bioluminescent photoprotein technology to detect active tooth demineralization in real time. It targets US dental practices with a capital-device plus consumable model following FDA Premarket Approval in January 2024.

What Calcivis does

Calcivis is an Edinburgh-based medical device company that develops and commercializes the CALCIVIS Imaging System, a chairside dental diagnostic that uses a recombinant bioluminescent photoprotein to visualize free calcium ions released from actively demineralizing tooth surfaces. The system pairs a biologic reagent (sprayed onto the tooth) with a custom imaging device and proprietary overlay software to produce real-time demineralization maps, enabling dental practitioners to differentiate active from inactive caries lesions and detect subclinical demineralization that conventional visual-tactile methods miss in up to 70% of pre-cavitated cases. The company positions the product as the first application of bioluminescence in preventive dentistry, addressing a global disease — dental caries — that affects roughly 35% of the world population.

The business operates a hybrid capital-equipment + consumable model: the imaging device represents a one-time capital sale to dental practices, while the photoprotein reagent is consumed per procedure and generates recurring usage-based revenue. Calcivis sells exclusively through a direct enterprise field-sales motion with consultative demos, currently limited to the United States following FDA Premarket Approval secured in January 2024 (the first Scottish medical device to achieve this milestone). The company also holds a UKCA mark for the UK market and has publicly stated plans for UK and European expansion once the US launch is established.

The company was co-founded in 2012 by Adam Christie and Bruce Vernon, is backed by the Scottish National Investment Bank, Investment Fund for Scotland, Archangels, and Scottish Enterprise, and transitioned leadership in April 2025 to Greg Sheehan (formerly VP of Global Endodontic Platform at Dentsply Sirona) to professionalize the commercial phase. Operating geographies are the UK (headquarters at Edinburgh BioQuarter) and the US (Milton, Massachusetts), with headcount in the 1-10 range and total disclosed funding of approximately £28M+ across nine rounds since 2012.

Calcivis firmographics

Firmographics
Name
Calcivis
Legal name
Calcivis, Inc.
Website
https://calcivis.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
1–10 employees
Short description
Calcivis is an Edinburgh-based medical device company that sells the CALCIVIS Imaging System, a chairside dental diagnostic using bioluminescent photoprotein technology to detect active tooth demineralization in real time. It targets US dental practices with a capital-device plus consumable model following FDA Premarket Approval in January 2024.
Ownership category
akta.pro rank

Calcivis industry classification

Industry
Product category
Dental Diagnostic Imaging Equipment
NAICS
Dental Equipment and Supplies Manufacturing (339114)
SIC
Dental Equipment & Supplies (3843)
akta.pro industry
PRIMARYHLABAIAL
Dental Imaging Equipment Service, Calibration & QA Providers
Healthcare & Life Sciences/Dental Care Services/Dental Radiology & Imaging Centers
SECONDARYHLACALAK
Teleradiology Platforms & Reading Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • Dental imaging systems
  • Caries detection devices
  • Bioluminescent diagnostics
  • Preventive dentistry equipment
  • Dental medical devices

Where Calcivis is headquartered

Location

Headquarters

HQ city
Edinburgh
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Calcivis business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Marketing or Sales, Personnel, Supply Chain, Operations

Revenue model

  1. Medical Device Sales (Imaging System): Sale of the CALCIVIS Imaging System device - a dental imaging apparatus that includes the photoprotein delivery and imaging capture technology. This is a capital equipment sale model typical for medical devices.
  2. Consumables (Photoprotein Agent): Recurring revenue from the biologic diagnostic agent (photoprotein) that is consumed during each imaging procedure. The photoprotein is sprayed onto tooth surfaces and reacts with calcium ions to produce the bioluminescent signal.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Calcivis product offering

Product offering

Core offering

Calcivis develops and commercializes the CALCIVIS Imaging System, a dental medical device that uses a proprietary recombinant photoprotein to react with free calcium ions released from actively demineralizing tooth surfaces, producing a real-time bioluminescent signal. The system consists of an imaging device, a consumable photoprotein reagent, and proprietary software that overlays visible and luminescent images to provide chairside maps of active caries lesion demineralization, enabling early detection and monitoring of tooth decay.

Product overview

Calcivis offers a single unified product: the CALCIVIS® Imaging System, which consists of a bioluminescent photoprotein reagent (a biologic diagnostic agent), an imaging device, and proprietary software. The system represents the first application of bioluminescence in preventive dentistry, enabling real-time chairside assessment of caries lesion activity by detecting free calcium ions released during active demineralization. The imaging device applies the photoprotein and simultaneously captures bioluminescent reaction images, which are overlaid with visible images to generate demineralization maps for early detection and monitoring of dental caries.

Differentiator

Problem solved

Functional benefit

Products and services

  • CALCIVIS Imaging System A bioluminescence-based dental imaging system that detects and assesses demineralization associated with carious lesions in real time. It consists of a hand-held imaging device, a consumable recombinant photoprotein reagent that reacts with free calcium ions released from actively demineralizing tooth surfaces, and proprietary software that overlays visible and luminescent images to provide chairside demineralization maps. It is intended for general dental practitioners, hygienists, and dental practices performing routine examinations and preventive dentistry for patients aged 6 and above, and is currently available for sale in the United States only.

Quantifiable outcome

  • Conventional diagnostic methods miss up to 70% of pre-cavitated caries lesions
  • +3 more outcomes

Companies that use Calcivis

Customer profile

Segments1 record

Ideal customer profiles1 record

Calcivis technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Calcivis partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Calcivis competitors and assessment

Company assessment

Direct peers

  • KaVo Dental (Envista): Manufacturer of DIAGNOdent, the leading laser fluorescence caries detection device used chairside by dental practices. Most direct competitor to CALCIVIS in the early caries detection workflow, serving the same preventive dentistry customer segment.
  • Acteon Group: Manufacturer of Sopro intraoral cameras and the SoproLife/SOPROcare fluorescence-based caries detection devices. Directly competes with CALCIVIS in the dental imaging and caries detection category, targeting the same dental practitioner use case.
  • Air Techniques: US-based manufacturer of dental imaging systems including Spectra (caries detection camera) and ProVecta intraoral imaging. Direct competitor in the dental imaging device category with overlapping sales channels into North American dental practices.

Broad incumbents

  • DEXcowin / iTero (Align Technology): Align Technology (iTero) sells intraoral scanners and NIRI (near-infrared imaging) caries detection capability within its imaging platform. Broad incumbent adding AI-driven caries detection features that could compete with or complement CALCIVIS in digitally-enabled dental practices.
  • Midmark Corporation: US manufacturer of dental equipment including imaging systems, chairs, and delivery units. Serves the same dental practice customer base with overlapping capital equipment sales motion into general dentistry offices.
  • Dentsply Sirona: Largest global dental equipment and consumables manufacturer offering imaging systems (X-ray, intraoral cameras), restorative materials, and endodontic solutions. New Calcivis CEO Greg Sheehan previously served as VP of Global Endodontic Platform here, making it the most strategically relevant incumbent peer.
  • 3Shape: Global dental technology company offering TRIOS intraoral scanners, imaging software, and CAD/CAM workflows. Adjacent competitor in dental digital imaging with overlapping practitioner customers and growing AI-powered diagnostic capabilities.
  • NSK Nakanishi: Japanese manufacturer of dental handpieces, scalers, and small equipment sold globally through dental distribution. Comparable in selling capital equipment and consumables into the same dental practice channel as Calcivis targets.

Emerging players

  • Quantum Dental Technologies: Developer of The Canary System, a laser-based caries detection device using PTR-LUM technology. Niche emerging competitor pursuing the same chairside early caries detection opportunity with a different underlying physics.
  • Wagstaff & Cartwright / Vista Dental: Smaller dental technology manufacturer selling diagnostic and preventive products into dental practices. Comparable go-to-market through dental distribution and overlapping preventive dentistry positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Calcivis social profiles

Digital presence

Calcivis compliance and trust

Trust signal

Compliance2 records

Calcivis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Calcivis leadership team

Management profile

Number of profiles

Profiles7 records

Calcivis funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Calcivis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Calcivis

What does Calcivis do?

Calcivis develops and commercializes the CALCIVIS Imaging System, a dental medical device that uses a proprietary recombinant photoprotein to react with free calcium ions released from actively demineralizing tooth surfaces, producing a real-time bioluminescent signal. The system consists of an imaging device, a consumable photoprotein reagent, and proprietary software that overlays visible and luminescent images to provide chairside maps of active caries lesion demineralization, enabling early detection and monitoring of tooth decay.

Is Calcivis a public or private company?

Calcivis is a private company. It is classified as venture growth investor backed and is currently operating.

When was Calcivis founded?

Calcivis was founded in 2012. It employs 1 to 10 people.

Where is Calcivis based?

Calcivis is headquartered in Edinburgh, United Kingdom, in the Europe region.

How does Calcivis make money?

Two revenue lines are on record. Medical Device Sales (Imaging System) is the primary driver. The others are consumables (Photoprotein Agent).

Who are Calcivis's main competitors?

Direct peers on record are KaVo Dental (Envista), Acteon Group and Air Techniques. Broad incumbents are DEXcowin / iTero (Align Technology), Midmark Corporation, Dentsply Sirona, 3Shape and NSK Nakanishi. Emerging players are Quantum Dental Technologies and Wagstaff & Cartwright / Vista Dental.

Does Calcivis have an API?

No public API is recorded for Calcivis.

What industry is Calcivis in?

Calcivis's product category is Dental Diagnostic Imaging Equipment. Its primary akta.pro industry code is HLABAIAL, Dental Imaging Equipment Service, Calibration & QA Providers, with a secondary code of HLACALAK, Teleradiology Platforms & Reading Workflow. Its NAICS code is 339114 and its SIC code is 3843.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Scotland NewsAll jobs lost as Scottish company placed into administrationCalcivis Limited, an Edinburgh-based dental diagnostic firm, entered administration after failing to achieve profitability despite public and private backing. The Scottish National Investment Bank had committed £5 million, and an angel syndicate raised £3 million, but the company could not secure a sale or funding solution within the required timeframe.Scotland NewsAll jobs lost as Scottish company placed into administrationCalcivis Limited, an Edinburgh-based dental diagnostic technology firm, entered administration after failing to achieve profitability despite public and private backing. The company employed nine in 2024, with SNIB having committed £5 million, and administrators will seek to realise remaining assets for creditors.Towards HealthcareDigital Dental Diagnosis and Treatment Service Companies, Business & Management OutlookThis article provides a comprehensive market overview of the digital dental diagnosis and treatment service industry, covering key technologies such as AI, CAD/CAM, 3D imaging, and intraoral scanning that are transforming oral healthcare. The report highlights market growth projections from 2026 to 2035, with revenues expected to reach into the hundreds of millions, driven by consumer preferences and technological advancements. Specific recent developments include Institut Straumann AG's acquisition of a digital AI startup in March 2025, Solventum Corporation's partnership with SprintRay for same-day dental crowns in March 2025, and Calcivis receiving FDA Pre-Market Approval for its bioluminescent imaging device in January 2024.GlobeNewswireCalcivis appoints Greg Sheehan as CEOCalcivis appointed Greg Sheehan as CEO, bringing 28 years of dental industry experience from Dentsply Sirona. He will focus on accelerating adoption of the CALCIVIS Imaging System in the US, which has FDA pre-market approval. The system detects early tooth decay via bioluminescent photoprotein.MavencpIFS Maven Equity Finance invests £1 million in dental pioneer CalcivisIFS Maven Equity Finance has invested £1 million in dental technology company Calcivis to support the global launch of its bioluminescence-based diagnostic device. This funding follows FDA premarket approval, enabling Calcivis to enter the US market first before expanding to the UK and Europe.Thebank£5m investment helps Scottish dental biotech prevent decayEdinburgh-based biotechnology firm Calcivis has secured £5m in funding to launch its dental technology that enables early detection of tooth decay. The investment includes £4m from the Scottish National Investment Bank and £1m from IFS Maven Equity Finance, which will support Calcivis in bringing its flagship product to the US market after receiving FDA premarket approval. Calcivis aims to revolutionize early-intervention diagnostics in dentistry with this innovative technology, which has the potential to significantly impact oral health care globally.Calcivis£5m Investment Helps Scottish Dental Biotech Prevent DecayCALCIVIS®, a biotechnology firm based in Edinburgh, has secured £5m in funding from the Scottish National Investment Bank and the Investment Fund for Scotland to roll out its dental technology for detecting tooth decay. This funding will support the launch of their product in the US market following FDA premarket approval, marking it as the first Scottish medical device to receive this certification. With plans for subsequent launches in the UK and Europe, CALCIVIS® aims to transform preventive dentistry.Dentistry TodayCALCIVIS to Launch Revolutionary New Bioluminescent Dental Imaging System in the USCalcivis, a Scotland-based company, launched a new bioluminescent dental imaging system in the US after FDA approval, with a US headquarters in Milton, MA. The company plans a limited release in Boston in early 2024 and aims to improve early detection of dental decay to enable preventive treatment.